Navigation Links
Springer expands publishing partnership with the Biomedical Engineering Society
Date:3/13/2008

Springer and the Biomedical Engineering Society (BMES) will launch a new international journal called Cellular and Molecular Bioengineering (CMBE) in March 2008. Springer is already the publisher of the BMES journal Annals of Biomedical Engineering.

Cellular and Molecular Bioengineering will publish first-rate articles in the frontier areas of cellular and molecular bioengineering, thus advancing this rapidly evolving new field that addresses problems at the interface of cellular-molecular biology and engineering. The overarching aim is to foster the understanding of mechanical, chemical, and electrical processes to better understand the integrated systems nature of cellular and molecular processes. The scope of the journal includes behaviors of biomolecules, behaviors of cells, computational modeling of molecules and cells, and experimental methods for cellular and molecular bioengineering. The expert international editorial board is headed by co-editors X. Edward Guo of Columbia University, NY, and David J. Odde of the University of Minnesota.

Shu Chien, President of the BMES, said, The publication of the new journal Cellular and Molecular Bioengineering in the interdisciplinary field of biomedical engineering is one of the most important developments at the BMES in this new century. With the publication of our second official BMES journal, in addition to the Annals of Biomedical Engineering, we have amplified the successful cooperation between BMES and Springer in publishing top-quality journals in biomedical engineering. The two journals will play major roles in accomplishing BMES' mission to promote and enhance biomedical knowledge worldwide and its utilization for the health and well-being of humankind."

Aaron Johnson, Senior Editor, Biomedical Engineering at Springer, said, The Biomedical Engineering Society has long been a leader in the science, translation and application of biomedical engineering research to the improvement of the human condition. A key challenge in improving human health is to understand how cellular behavior arises from molecular-level interactions. Cellular and Molecular Bioengineering serves as a new forum in understanding this relationship, indicative of the BMES' vision and leadership. Together with the BMES flagship journal, Annals of Biomedical Engineering, the new journal CMBE continues the Societys charter of excellence in biomedical engineering, and Springer is proud to be the publishing partner in this new initiative.

Springer will publish Cellular and Molecular Bioengineering quarterly in both print and electronic formats. It will be available on www.springerlink.com, Springers online information platform and will include fast, electronic publication in Online First, as well as Cross Reference Linking and Table of Contents Alerts. In addition, all potential authors have the option, through the Springer Open Choice program, of publishing their articles using the open access publishing model.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related biology news :

1. Springer author Carlos M. Duarte awarded Spanish science prize
2. Humana Press journals now available on SpringerLink
3. Springer launches Tropical Plant Biology
4. Springer founds new journal Air Quality, Atmosphere and Health
5. Springer and the New York Botanical Garden Press join forces to publish botanical journals
6. Estuarine Research Federation chooses Springer as publishing partner
7. Springer book wins Quality of Communication Award
8. Springer will publish Journal of Coastal Conservation
9. Springer increases publishing activities in South Korea
10. DHS Expands Biometrics-at-Sea Program to the Florida Straits
11. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:8/15/2017)... ivWatch LLC , a medical device company focused on improving the ... its ISO 13485 Certification, the global standard for medical device quality ... ... device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates ...
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology: